Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for HIV Immunological Non-Responders
NCT03568812Phase 2Completed
- Sponsor
- Universitas Indonesia
- Start
- May 2018
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Universitas Indonesia. Primary endpoint: CD4+ Cell Count at 12 weeks. Started May 2018; status: completed.
Beyond the preview
Go deeper on NCT03568812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03568812.